Welcome to our dedicated page for Bleichroeder Acquisition II-A SEC filings (Ticker: BBCQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Bleichroeder Acquisition II-A's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Bleichroeder Acquisition II-A's regulatory disclosures and financial reporting.
Bleichroeder Acquisition Corp. II and Pasqal Holding SAS disclosed plans for a business combination and capital raise to support Pasqal’s commercialization of neutral-atom quantum computers. The presentation highlights €340M in new funding, planned Nasdaq listing in H2 2026, enterprise QPU deployments, and manufacturing scale-up to expand cloud access and vertical use cases.
The CEO described seven operational high‑qubit QPUs, three more in production, partnerships with cloud and HPC providers, and a roadmap toward fault‑tolerant quantum computing (phase transition toward 2030+).
Bleichroeder Acquisition Corp. II reports that Bleichroeder Sponsor 2 LLC and affiliated reporting persons beneficially hold 9,583,333 Class B Ordinary Shares, representing 25.0% of the company's ordinary shares. These Class B shares are convertible into Class A Ordinary Shares on a one-for-one basis, subject to anti-dilution adjustments as described in the registration statement.
Based on the issuer's Form 10-K, the company had 38,333,333 ordinary shares outstanding as of March 16, 2026 (comprised of 28,750,000 Class A and 9,583,333 Class B). The filing discloses shared voting and dispositive power over the reported Class B shares by the Sponsor, Bleichroeder Manager 2 LLC, Andrew Gundlach, and Michel Combes, and notes 5,000,000 private placement warrants held by the Sponsor exercisable at $11.50 per share not exercisable within 60 days.
Bleichroeder Acquisition 2 France II filed a communication describing Pasqal and IQM's planned U.S. public listings via SPAC mergers to access late-stage capital and prepare for industry consolidation. The filing and accompanying discussion note Europe’s €3bn ScaleUp Europe initiative and a proposed €5bn target to bolster deep tech funding.
The communication discloses forward-looking statements about the proposed business combination with Pasqal, associated risks, the planned Form F-4 registration, and references to past fundraising and potential market consolidation.
Bleichroeder Acquisition 2 France, II announced a proposed business combination to take Pasqal public via merger, valuing Pasqal at $2 billion pre-money. The combined company is expected to list on the Nasdaq and Bleichroeder intends to file a Form F-4/registration statement in connection with the shareholder vote.
Pasqal plans to expand U.S. operations, selecting Chicago for a domestic headquarters with a pledged investment of $65 million and creation of 50 full-time jobs. The communication includes customary forward-looking statements and directs investors to review the forthcoming registration statement and proxy materials.
Pasqal announced a strategic collaboration with True Nexus to apply neutral-atom quantum computing to modeling protein functionality for food applications as Pasqal pursues a business combination with Bleichroeder Acquisition Corp. II. The work targets a fully vectorized, dynamic 3D model of protein gelation to improve prediction of gelatin, texture, and behavior in complex food systems.
The collaboration aims to create a reference model usable by food and ingredient companies for seed development, crop optimization, and precision fermentation; statements are forward‑looking and conditioned on completion of the proposed business combination and other customary risks.
Bleichroeder Acquisition II and Pasqal are progressing a proposed business combination that would bring Pasqal public. Pasqal plans a U.S. Nasdaq listing and a later Euronext listing. The companies describe a $52.84 million investment and creation of 51 jobs for a Seoul R&D center.
Pasqal highlights its neutral-atom quantum systems (about 200 qubits shown), manufacturing cadence of roughly 9–12 months per unit, production capacity expansions including a Canadian facility, and customer deployments with GENCI, Aramco and European partners. Statements include forward-looking qualifiers and a Form F-4 registration process.
Pasqal announced integration of NVIDIA CUDA-Q into its QRMI runtime, making Pasqal neutral-atom quantum processors schedulable as native accelerators within Slurm-based HPC workflows. The integration permits CUDA-Q workloads to be orchestrated alongside CPUs and GPUs via standard Slurm job submission, allocation, authentication, and monitoring. Pasqal says QRMI is hardware-, modality- and vendor-agnostic and that the capability is available on Pasqal’s cloud platform and planned for on-premises deployment at CINECA with the Leonardo pre-exascale supercomputer. The announcement follows Pasqal’s path to a business combination with Bleichroeder Acquisition Corp. II.
Bleichroeder Acquisition Corp., a Cayman Islands-based blank check company, filed its annual report describing progress toward completing its first business combination. The company targets technology, media and telecommunications and other sectors undergoing digital transformation.
After the reporting period, it completed an IPO on January 9, 2026, selling 28,750,000 units at $10.00 each and placing $287,500,000 into a trust account, alongside a private sale of 7,750,000 private placement warrants. The SPAC must close a business combination by January 9, 2028 or return trust funds to public shareholders.
On February 28, 2026, it signed a Business Combination Agreement with Pasqal Holding SAS, expected to be funded by the trust and a PIPE, with closing targeted for the second half of 2026, subject to regulatory and shareholder approvals. As of March 16, 2026, there were 28,750,000 Class A and 9,583,333 Class B ordinary shares outstanding, no material litigation, and the company highlighted cybersecurity and SPAC-specific regulatory risks.
Bleichroeder Acquisition Corp. II disclosed an article reporting that Pasqal Holding SAS plans a business combination with Bleichroeder that targets a dual listing on the Nasdaq and Euronext Paris and a valuation of $2 billion. Pasqal seeks €340 million in financing in two tranches, including a €170 million fundraise from Parkway, Quanta Computer, LG Electronics and CMA CGM and a €170 million convertible private placement. The company plans a SPAC path to the Nasdaq in 2026 and preparatory work for a Paris IPO in 2026 or 2027. Pasqal expects to launch its Vela machine in 2026 with about 250 qubits and aims to double production capacity within 24 months and pursue a fault-tolerant quantum computer by 2030.
Bleichroeder Acquisition Corp. II entered into a Business Combination Agreement to merge with Pasqal, valuing Pasqal at $2.0 billion pre-money. The transaction contemplates a French reincorporation merger and a fusion-absorption merger to form New Pasqal, and is expected to close in the second half of 2026, subject to customary closing conditions including shareholder and regulatory approvals and listing on Nasdaq.
The deal includes a concurrent private placement: a $250 million aggregate principal amount of senior unsecured convertible bonds (sold for an aggregate purchase price of $200 million reflecting a 20.0% original issue discount) and Investment Warrants equal to 125% of the initial convertible shares. Convertible bonds carry interest at 10.0% per annum with PIK mechanics, an initial conversion price of $12.00, and customary protective and redemption features.